Skip to main content

#158408

Anti-CUGBP2/ETR-3 [1H2-1F12]

Cat. #158408

Anti-CUGBP2/ETR-3 [1H2-1F12]

Cat. #: 158408

Unit size: 100 ug

Availability: 10-12 weeks

Target: CUGBP2/ETR-3 (Elav-like family member 2)

Class: Monoclonal

Application: WB ; IHC ; IF ; IP

Reactivity: Human ; Rat ; Mouse

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Florida

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CUGBP2/ETR-3 [1H2-1F12]
  • Alternate name: BRUNOL3, NAPOR; CELF2
  • Research fields: Genetics;Tissue-specific biology
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 52
  • Reactivity: Human ; Rat ; Mouse
  • Host: Mouse
  • Application: WB ; IHC ; IF ; IP
  • Description: CUGBP2/ETR-3 is an RNA-binding protein containing 2 N-terminal and 1 C-terminal RNA recognition motifs. It has been shown to interact wtih A1CF. This protein promotes exon inclusion and its activities are required for appropriate splicing in cardiomyocytes. During development ETR-3 is expressed in the heart in both the nucleus and cytoplasm and its expression is down-regulated during heart development.
  • Immunogen: Synthetic peptide corresponding to amino acids 209-415 of human CuGBP2
  • Isotype: IgG1

Target Details

  • Target: CUGBP2/ETR-3 (Elav-like family member 2)
  • Molecular weight: 52
  • Target background: CUGBP2/ETR-3 is an RNA-binding protein containing 2 N-terminal and 1 C-terminal RNA recognition motifs. It has been shown to interact wtih A1CF. This protein promotes exon inclusion and its activities are required for appropriate splicing in cardiomyocytes. During development ETR-3 is expressed in the heart in both the nucleus and cytoplasm and its expression is down-regulated during heart development.

Applications

  • Application: WB ; IHC ; IF ; IP

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Ladd et al. 2005. Dev Dyn. 233(3):783-93. PMID: 15830352.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.